Authors: Dutta, AS Gormley, JJ Coath, M Hassall, L Hayward, CF Gellert, PR Kittlety, RS Alcock, PJ Ferguson, R Halterman, T Jamieson, A Moors, JA Moores, JM Rees, A Wood, LJ Reilly, CF Haworth, D

Citation: As. Dutta et al., Potent cyclic peptide inhibitors of VLA-4 (alpha(4)beta(1) integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation, J PEPT SCI, 6(8), 2000, pp. 398-412

Authors: Dutta, AS Crowther, M Gormley, JJ Hassall, L Hayward, CF Gellert, PR Kittlety, RS Alcock, PJ Jamieson, A Moores, JM Rees, A Wood, LJ Reilly, CF Haworth, D

Citation: As. Dutta et al., Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha(4)beta(1) integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide, J PEPT SCI, 6(7), 2000, pp. 321-341

Authors: Furlong, ST Dutta, AS Coath, MM Gormley, JJ Hubbs, SJ Lloyd, D Mauger, RC Strimpler, AM Sylvester, MA Scott, CW Edwards, PD

Citation: St. Furlong et al., C3 activation is inhibited by analogs of compstatin but not by serine protease inhibitors or peptidyl alpha-ketoheterocycles, IMMUNOPHARM, 48(2), 2000, pp. 199-212

Authors: Haworth, D Rees, A Alcock, PJ Wood, LJ Dutta, AS Gormley, JJ Jones, HB Jamieson, A Reilly, CF

Citation: D. Haworth et al., Anti-inflammatory activity of c(ILDV-NH(CH2)(5)CO), a novel, selective, cyclic peptide inhibitor of VLA-4-mediated cell adhesion, BR J PHARM, 126(8), 1999, pp. 1751-1760